Home>R&D>R&D System

R&D System

The Group has formed and internationalized R&D structure, enhanced its strong R&D capabilities, and established an interactive and integrated R&D system in China, the United States, India, etc.

At the end of 2018, Fosun Pharma had a total of 215 projects: 15 small molecular innovative drugs, 10 biological innovative drugs, 17 biosimilars, 117 generic drugs that meet international standards, 54 consistency evaluation projects, and 2 traditional Chinese medicine drugs.